Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Govind Babu

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Indian Journal of Cancer|April 6, 2019
Every distant deposit is not a metastasis: Synchronous primaries do existGovind Babu, Vikas Asati, K C Lakshmaiah, et al.
Journal of Cancer Research and Therapeutics|May 17, 2017
Colorectal cancer presenting as bone metastasisM C Suresh Babu, Sunny Garg, K C Lakshmaiah, et al.
South Asian Journal of Cancer|February 16, 2019
Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South IndiaBabu Suresh, Vikas Asati, K C Lakshmaiah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Clinical experience with gefitinib in Indian patientsPurvish Parikh, Alex Yuang-Chi Chang, Shona Nag, et al.
Chinese Medical Journal|October 10, 2024
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2- advanced breast cancer: Final results of the randomized phase III MONARCH plus trialXichun Hu, Qingyuan Zhang, Tao Sun, et al.
Cancer Research and Treatment|March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup AnalysisByoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.
The Lancet. Haematology|July 18, 2017
Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled studyWojciech Jurczak, Ilídia Moreira, Govind Babu Kanakasetty, et al.
World Journal of Oncology|November 18, 2017
Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South IndiaK C Lakshmaiah, Abhishek Anand, K Govind Babu, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2- advanced breast cancerDebu Tripathy, Tristan Curteis, Sara Hurvitz, et al.
European Journal of Haematology|March 24, 2018
Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphomaK C Lakshmaiah, Vikas Asati, Govind Babu K, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Indian Journal of Cancer|April 6, 2019
Every distant deposit is not a metastasis: Synchronous primaries do existGovind Babu, Vikas Asati, K C Lakshmaiah, et al.
Journal of Cancer Research and Therapeutics|May 17, 2017
Colorectal cancer presenting as bone metastasisM C Suresh Babu, Sunny Garg, K C Lakshmaiah, et al.
South Asian Journal of Cancer|February 16, 2019
Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South IndiaBabu Suresh, Vikas Asati, K C Lakshmaiah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Clinical experience with gefitinib in Indian patientsPurvish Parikh, Alex Yuang-Chi Chang, Shona Nag, et al.
Chinese Medical Journal|October 10, 2024
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2- advanced breast cancer: Final results of the randomized phase III MONARCH plus trialXichun Hu, Qingyuan Zhang, Tao Sun, et al.
Cancer Research and Treatment|March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup AnalysisByoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.
The Lancet. Haematology|July 18, 2017
Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled studyWojciech Jurczak, Ilídia Moreira, Govind Babu Kanakasetty, et al.
World Journal of Oncology|November 18, 2017
Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South IndiaK C Lakshmaiah, Abhishek Anand, K Govind Babu, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2- advanced breast cancerDebu Tripathy, Tristan Curteis, Sara Hurvitz, et al.
European Journal of Haematology|March 24, 2018
Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphomaK C Lakshmaiah, Vikas Asati, Govind Babu K, et al.
Pageof 12